ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SHC vs AGL // 10Y YIELD & FRED MACRO BETA

Sotera Health Company (NASDAQ) VS. agilon health inc. (NYSE) • 15-METRIC TALLY: SHC 8 — AGL 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SHC VS. AGL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SHC AGL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 55.50% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 3.10% -35.00% +38.10 SHC /roic <GO>
EV/EBITDA & P/E Valuation 33.5x — — TIE /valuation <GO>
Free Cash Flow Yield 2.80% -8.25% +11.05 SHC /fcf-yield <GO>
Operating Margin 8.20% -7.80% +16.00 SHC /operating-margins <GO>
Net Profit Margin 6.70% -6.60% +13.30 SHC /net-margins <GO>
Revenue Growth (YoY) 5.70% -2.10% +7.80 SHC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.56 2.06 -0.50 AGL /balance-sheet <GO>
Piotroski F-Score Quality 8/9 3/9 +5.00 SHC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.5 44.4 +3.10 SHC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE 1.10 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 63.7x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.18B $1.43B $3.75B SHC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SHC REV AGL REV SHC GROSS % AGL GROSS % SHC FCF AGL FCF
FY 2025 $1.16B $5.93B 55.5% — $149.2M -$119.0M
FY 2024 $1.10B $6.06B 54.7% — $45.1M -$71.0M
FY 2023 $1.05B $4.32B — — -$194.9M -$156.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SHC // BETA 1.10
AGL // BETA —